Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  acute myeloid leukemia/transient myeloproliferative disorder
Stage/Subtype:  acute myeloid leukemia/transient myeloproliferative disorder
Country:  U.S.A.
Trial Type:  Treatment
Results 1-1 of 1 for your search:
Start Over
Neratinib in Treating Pediatric Patients with Recurrent or Refractory Solid Tumors or Hematologic Malignancies
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 6 to 21
Trial IDs: 16-878, NCI-2016-01571, NCT02932280
Start Over